The store will not work correctly when cookies are disabled.
4-bromo-N-(4-chloro-2-(trifluoromethyl)phenyl)-1,5-dimethyl-1H-pyrazole-3-carboxamide
ID: ALA4849879
PubChem CID: 4082920
Max Phase: Preclinical
Molecular Formula: C13H10BrClF3N3O
Molecular Weight: 396.59
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(Br)c(C(=O)Nc2ccc(Cl)cc2C(F)(F)F)nn1C
Standard InChI: InChI=1S/C13H10BrClF3N3O/c1-6-10(14)11(20-21(6)2)12(22)19-9-4-3-7(15)5-8(9)13(16,17)18/h3-5H,1-2H3,(H,19,22)
Standard InChI Key: DYGHWEBOYBMJIT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
6.1527 -16.3373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1516 -17.1647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8663 -17.5775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5828 -17.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5799 -16.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8645 -15.9246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2928 -15.9185 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.8661 -18.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1516 -18.8148 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.5805 -18.8152 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.8582 -19.2248 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.4367 -17.5766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7226 -17.1635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0078 -17.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7233 -16.3386 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2578 -17.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7054 -17.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1173 -18.5691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9243 -18.3980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0866 -16.4346 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2.7812 -19.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8849 -17.7674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
3 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
2 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 14 2 0
16 20 1 0
18 21 1 0
17 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.59 | Molecular Weight (Monoisotopic): 394.9648 | AlogP: 4.42 | #Rotatable Bonds: 2 |
Polar Surface Area: 46.92 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.54 | CX Basic pKa: ┄ | CX LogP: 4.33 | CX LogD: 4.33 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.82 | Np Likeness Score: -2.31 |
References
1. Richardson NL, O'Malley LJ, Weissberger D, Tumber A, Schofield CJ, Griffith R, Jones NM, Hunter L.. (2021) Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2., 38 [PMID:33862469] [10.1016/j.bmc.2021.116115] |